PURPOSE: There is a need to investigate the type, duration, frequency, and intensity of physical activity that are critical to reduce the risk of breast cancer, and if this relation differs among subgroups of women. METHODS: We analyzed the relation between physical activity and breast cancer incidence between 1990 and 2002 (n=3,424 cases), among 90,509 women of the French E3N cohort, ages between 40 and 65 years in 1990. We gave special attention to effect modification by body mass index (BMI), family history of breast cancer, parity, and hormone replacement therapy (HRT). RESULTS: A linear decrease in risk of breast cancer was observed with increasing amounts of moderate (P(trend)<0.01) and vigorous (P(trend)<0.0001) recreational activities. Compared with women who reported no recreational activities, those with more than five weekly hours of vigorous recreational activity had a relative risk of 0.62 (0.49-0.78). This decrease was still observed among women who were overweight, nulliparous, had a family history of breast cancer, or used HRT. Compared with the whole cohort, among nulliparous women, the reduction of risk observed was of a higher magnitude, although the test for heterogeneity did not reach statistical significance. CONCLUSION: A risk reduction of breast cancer was particularly observed with vigorous recreational activity. Further investigations are needed to confirm that intensity is an important variable to consider in risk reduction and to identify the precise biological mechanisms involved in such a risk reduction. (Cancer Epidemiol Biomarkers Prev 2006;15(1):57-64).
PURPOSE: There is a need to investigate the type, duration, frequency, and intensity of physical activity that are critical to reduce the risk of breast cancer, and if this relation differs among subgroups of women. METHODS: We analyzed the relation between physical activity and breast cancer incidence between 1990 and 2002 (n=3,424 cases), among 90,509 women of the French E3N cohort, ages between 40 and 65 years in 1990. We gave special attention to effect modification by body mass index (BMI), family history of breast cancer, parity, and hormone replacement therapy (HRT). RESULTS: A linear decrease in risk of breast cancer was observed with increasing amounts of moderate (P(trend)<0.01) and vigorous (P(trend)<0.0001) recreational activities. Compared with women who reported no recreational activities, those with more than five weekly hours of vigorous recreational activity had a relative risk of 0.62 (0.49-0.78). This decrease was still observed among women who were overweight, nulliparous, had a family history of breast cancer, or used HRT. Compared with the whole cohort, among nulliparous women, the reduction of risk observed was of a higher magnitude, although the test for heterogeneity did not reach statistical significance. CONCLUSION: A risk reduction of breast cancer was particularly observed with vigorous recreational activity. Further investigations are needed to confirm that intensity is an important variable to consider in risk reduction and to identify the precise biological mechanisms involved in such a risk reduction. (Cancer Epidemiol Biomarkers Prev 2006;15(1):57-64).
Authors: Darren Er Warburton; Sarah Charlesworth; Adam Ivey; Lindsay Nettlefold; Shannon Sd Bredin Journal: Int J Behav Nutr Phys Act Date: 2010-05-11 Impact factor: 6.457
Authors: Lauren E McCullough; Sybil M Eng; Patrick T Bradshaw; Rebecca J Cleveland; Susan L Teitelbaum; Alfred I Neugut; Marilie D Gammon Journal: Cancer Date: 2012-06-25 Impact factor: 6.860
Authors: E A Murphy; J M Davis; T L Barrilleaux; J L McClellan; J L Steiner; M D Carmichael; M M Pena; J R Hebert; J E Green Journal: Cytokine Date: 2011-05-19 Impact factor: 3.861
Authors: Stephanie M George; Melinda L Irwin; Charles E Matthews; Susan T Mayne; Mitchell H Gail; Steven C Moore; Demetrius Albanes; Rachel Ballard-Barbash; Albert R Hollenbeck; Arthur Schatzkin; Michael F Leitzmann Journal: Am J Public Health Date: 2010-09-23 Impact factor: 9.308
Authors: Adana A M Llanos; Jessica L Krok; Juan Peng; Michael L Pennell; Mara Z Vitolins; Cecilia R Degraffinreid; Electra D Paskett Journal: Horm Cancer Date: 2014-01-17 Impact factor: 3.869
Authors: Ying Liu; Deirdre K Tobias; Kathleen M Sturgeon; Bernard Rosner; Vasanti Malik; Elizabeth Cespedes; Amit D Joshi; A Heather Eliassen; Graham A Colditz Journal: Int J Cancer Date: 2016-05-17 Impact factor: 7.396
Authors: Ana I Faustino-Rocha; Adelina Gama; Paula A Oliveira; Antonieta Alvarado; Maria J Neuparth; Rita Ferreira; Mário Ginja Journal: Clin Exp Med Date: 2016-04-19 Impact factor: 3.984
Authors: Tricia M Peters; Steven C Moore; Gretchen L Gierach; Nicholas J Wareham; Ulf Ekelund; Albert R Hollenbeck; Arthur Schatzkin; Michael F Leitzmann Journal: BMC Cancer Date: 2009-10-01 Impact factor: 4.430